Estimated early-onset group B streptococcal neonatal disease
about
Group B Streptococcus vaccine development: present status and future considerations, with emphasis on perspectives for low and middle income countriesAetiology of community-acquired neonatal sepsis in low and middle income countriesNeonatal group B streptococcal disease: incidence, presentation, and mortality.Surface proteins of Streptococcus agalactiae and related proteins in other bacterial pathogens.Group B streptococcal carriage, serotype distribution and antibiotic susceptibilities in pregnant women at the time of delivery in a refugee population on the Thai-Myanmar border.Sensitivities of antigen detection and PCR assays greatly increased compared to that of the standard culture method for screening for group B streptococcus carriage in pregnant women.Abundance of the delta subunit of RNA polymerase is linked to the virulence of Streptococcus agalactiaeThe β-hemolysin and intracellular survival of Streptococcus agalactiae in human macrophagesReal-time polymerase chain reaction for the rapid detection of group B streptococcal colonization in neonatesC-Reactive Protein, Detected with a Highly Sensitive Assay, in Non-Infected Newborns and Those with Early Onset Infection.Risk score to stratify children with suspected serious bacterial infection: observational cohort studyEvaluation of temperature-pulse centile charts in identifying serious bacterial illness: observational cohort study.Carriage of group B streptococcus in pregnant women from Oxford, UK.Antepartum Membrane Stripping in GBS Carriers, Is It Safe? (The STRIP-G Study).Significance, management and prevention of Streptococcus agalactiae infection during the perinatal period.Vaccination against group B streptococcus.Could peripartum antibiotics have delayed health consequences for the infant?Group B Streptococcus: global incidence and vaccine development.Comparison Between Pathogen Associated Laboratory and Clinical Parameters in Early-Onset Sepsis of the Newborn.Molecular-based screening for perinatal group B streptococcal infection: implications for prevention and therapy.Early onset neonatal sepsis: diagnostic dilemmas and practical management.Prevention of Group B Streptococcus early-onset disease: a toolkit by the California Perinatal Quality Care Collaborative.Prevalence and risk factors of chorioamnionitis in Dhaka, Bangladesh.Group B streptococcus disease in neonates: to screen or not to screen?Evaluation of an in-house real-time polymerase chain reaction method to identify group B streptococcus colonization in pregnancy.Early-onset neonatal sepsis in Dhaka, Bangladesh: risk associated with maternal bacterial colonisation and chorioamnionitis.Transport of multidrug resistance substrates by the Streptococcus agalactiae hemolysin transporter.Evaluation of IL-8-concentrations in plasma and lysed EDTA-blood in healthy neonates and those with suspected early onset bacterial infection.Cost-effectiveness of different treatment strategies with intrapartum antibiotic prophylaxis to prevent early-onset group B streptococcal disease.Risk of Early-Onset Neonatal Group B Streptococcal Disease With Maternal Colonization Worldwide: Systematic Review and Meta-analyses.Cow's milk and the emergence of group B streptococcal disease in newborn babies.Re: Cost-effectiveness of different treatment strategies with intrapartum antibiotic prophylaxis to prevent early-onset group B streptococcal disease
P2860
Q28075884-39088E3B-FDF7-4C44-A8EC-943E0ECAEFABQ28714316-75811B7B-391F-4E53-A581-8217C55A2708Q33378153-EB6B02AB-B335-445A-98B0-BA7D590E82E1Q33719415-3DE63E74-5EA3-45A3-A026-CF2632C9C3B2Q34153694-48A0A332-9D78-4F73-97B4-9503FF2F41B6Q34432052-8AA8FCFE-5333-4ACC-B289-F52A6C39C057Q34513660-9A48DD60-9F3B-4A4F-A5BA-DF3E0DE98D15Q34672705-50059185-F78F-4ACE-84DD-616C5EC4BDDDQ34806368-3E0A8BB8-0BC1-43A8-B04B-12F0CDEF6A24Q34870402-FA7976DB-8BC2-453E-A3B7-A898665ADBA1Q35172359-F75DBEE2-C64F-41C5-9FC4-D8FCBCE2A1B1Q35172363-7CDAE6ED-4B1F-4ADA-925C-45CE29663547Q35769938-53B3AB4C-8DD1-4D54-A24C-FCE31C095B5CQ35882465-D8C19E37-615D-48B3-8314-8F84E40C0762Q35917434-6B0B68DD-83E9-435C-87E4-FDBD0B784968Q36124960-06BFAB2A-FAB5-4808-827A-9CC266FC0F25Q36530310-0B568CD2-37F3-4AD7-B20A-28A4C81DD762Q36646803-322CD23D-DF66-4EE7-968F-FDF588488645Q37081745-AE734E01-E921-404E-A3FE-AD156F42DD80Q38119909-38715240-B483-46D7-8D77-0F0FAE09B974Q38271541-A1C4AC1D-4ED2-42BA-A5BF-C41AEB203F1DQ38435222-CB725786-C8CD-40B4-B229-78E3A006FE05Q40088794-6050D9B1-A890-4148-B84A-E06063B76DC8Q40497962-6506E405-B890-429A-AC79-78121ACD2B1DQ41199614-146560B1-EAA9-4FEF-A3BB-CA8495F264F6Q42256552-5EBE537C-5610-42C4-AC24-26EE9D3E9010Q42578110-0A14806C-E93F-4492-9B87-9B00E3E82883Q44064201-06551C3B-F040-4AFE-86A8-C06F5EE0159DQ44503294-9C2DCD0A-23F0-456E-84E1-BA2AD5463895Q46873175-DBB6259F-E117-418E-B1D2-F6905CB2CBF3Q48623120-214FD758-B408-48DE-B106-DFBD2D294830Q59114995-3F533EB5-125D-4EF2-B9BE-A6F7736C795C
P2860
Estimated early-onset group B streptococcal neonatal disease
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Estimated early-onset group B streptococcal neonatal disease
@ast
Estimated early-onset group B streptococcal neonatal disease
@en
type
label
Estimated early-onset group B streptococcal neonatal disease
@ast
Estimated early-onset group B streptococcal neonatal disease
@en
prefLabel
Estimated early-onset group B streptococcal neonatal disease
@ast
Estimated early-onset group B streptococcal neonatal disease
@en
P2093
P3181
P1433
P1476
Estimated early-onset group B streptococcal neonatal disease
@en
P2093
Alison Bedford Russell
Alison Pitt
Aoadhan Breathnach
Katrina d'Agapeyeff
Michael Torny
Suzanne Luck
P304
P3181
P356
10.1016/S0140-6736(03)13553-2
P407
P50
P577
2003-06-01T00:00:00Z